undamentalytics Newsletter
Sign in

Sera Prognostics, Inc. balance sheet

At the end of fiscal 2025, Sera Prognostics, Inc. had total assets of $102m, total liabilities of $26.5m and shareholders' equity of $75.4m. It held $3.9m in cash against $0 of debt: net cash of $3.9m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents1459304444
Receivables0000000
Total current assets141109061484148
Total assets15147116957310287
Accounts payable0121211
Deferred revenue (current)03920202020
Total current liabilities1181624252424
Total debt4000000
Total liabilities1281725252727
Shareholders' equity−1261399970487559
Non-controlling interests and other (assets − liabilities − equity)128——————
Net debt (negative = net cash)−9−59−30−4−4−4−4

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: ACON vs SERAISPC vs SERASERA vs YDES

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Sera Prognostics, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Sera Prognostics, Inc.